Under the Microscope: Trends in Life Science Investments and Exits Online Seminar

 
Analytics; Life Science; Venture Capital
October 08, 2010 Posted by:

SVB Analytics' Web seminar focuses on trends in the Life Science sector, including venture capital financing, M&A, and IPO activity.  In this free replay of the seminar, you will hear a variety of viewpoints from our expert panel of venture capitalists who have investment experience in the Life Science sector, as well as valuation and research professionals from SVB.

See the Web seminar replay [PLAYBACK]
Read the presentation [PDF]
Read the article
 
Read the Q&A Summary [PDF]


Speakers:
Albert Cha, MD - Managing Partner, Vivo Ventures
Mark-Henri Galletti -  Managing Director, Longitude Capital
David Marr - Associate, SVB Analytics
Dan Zaelit- Research Associate, SVB Analytics
Jonathan Norris - Managing Director, Silicon Valley Bank (moderator)
Dave Krimm - Head of Strategy and Product Management, SVB Analytics


Among the topics discussed:

  • A Venture Capital perspective on valuing new deals and exit values in the Life Science sector
  • Life Science exit data including exit multiples, and time- and capital-to-exit
  • SVB Analytics' perspective on Life Science valuations
  • Operating Performance: trends in revenue, expense, cash position, and liquidity values

 

Comment

Not a Member?
Register now and join discussions in the SVB Professional network. Best of all, it's FREE.

Register Login to Comment

Terms of Service | Privacy Policy
 

Dave Krimm

Head of R&D,
SVB Analytics
Contact Me
View Profile
 
Content Subscription
Subscribe to Analytics
Subscribe to Life Science
Subscribe to Venture Capital